miRagen Therapeutics, Inc., is a clinical stage biopharmaceutical company discovering and developing innovative microRNA-targeting therapies to improve human health. At miRagen Therapeutics we leverage in-house expertise in microRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class microRNA-based technologies and high-potential drug candidates. We have developed ongoing, collaborative relationships with academic institutions that give us unique access to promising early-stage discoveries. This access to groundbreaking science provides a significant strategic advantage in the rapidly-developing field of microRNA-targeting therapeutics. Our microRNA development platform serves as the foundation for a diversified pipeline. Our therapeutic areas of focus include cancer, pathologic fibrosis, neuro-inflammatory, and cardiovascular diseases. Source
No articles found.
HealthStream (NASDAQ: HSTM) is dedicated to improving patient outcomes through the...
HealthStream (NASDAQ: HSTM) is dedicated to imp...
We are a commercial-stage biotech company focused on harnessing the inherent biolo...
We are a commercial-stage biotech company focus...
Intellia Therapeutics is a leading genome editing company focused on developing cu...
Intellia Therapeutics is a leading genome editi...
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company d...
ASLAN Pharmaceuticals is a clinical-stage oncol...
Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a...
Oramed Pharmaceuticals (NASDAQ: ORMP) was estab...
Otsuka Holdings Co Ltd is a pharmaceutical company. The Company manufactures, sell...
Otsuka Holdings Co Ltd is a pharmaceutical comp...
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and...
Headquartered in Cupertino, California, Aemetis...
Join the National Investor Network and get the latest information with your interests in mind.